- Home
- ADTN vs ELYM Comparison
ADTN vs ELYM Comparison
Compare ADTN & ELYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- ELYM
- Stock Information
- Founded
- ADTN 1985
- ELYM 2018
- Country
- ADTN United States
- ELYM United States
- Employees
- ADTN N/A
- ELYM N/A
- Industry
- ADTN Telecommunications Equipment
- ELYM Biotechnology: Pharmaceutical Preparations
- Sector
- ADTN Telecommunications
- ELYM Health Care
- Exchange
- ADTN Nasdaq
- ELYM Nasdaq
- Market Cap
- ADTN 454.0M
- ELYM 440.8M
- IPO Year
- ADTN 1994
- ELYM 2021
- Fundamental
- Price
- ADTN $5.05
- ELYM $7.39
- Analyst Decision
- ADTN Buy
- ELYM
- Analyst Count
- ADTN 3
- ELYM 0
- Target Price
- ADTN $7.00
- ELYM N/A
- AVG Volume (30 Days)
- ADTN 419.1K
- ELYM 260.6K
- Earning Date
- ADTN 08-05-2024
- ELYM 08-14-2024
- Dividend Yield
- ADTN 7.13%
- ELYM N/A
- EPS Growth
- ADTN N/A
- ELYM N/A
- EPS
- ADTN N/A
- ELYM N/A
- Revenue
- ADTN $949,974,000.00
- ELYM N/A
- Revenue This Year
- ADTN $50.29
- ELYM N/A
- Revenue Next Year
- ADTN N/A
- ELYM N/A
- P/E Ratio
- ADTN N/A
- ELYM N/A
- Revenue Growth
- ADTN N/A
- ELYM N/A
- 52 Week Low
- ADTN $4.34
- ELYM $2.35
- 52 Week High
- ADTN $8.56
- ELYM $11.55
- Technical
- Relative Strength Index (RSI)
- ADTN 41.74
- ELYM 57.40
- Support Level
- ADTN $5.31
- ELYM $5.65
- Resistance Level
- ADTN $5.87
- ELYM $7.89
- Average True Range (ATR)
- ADTN 0.20
- ELYM 0.50
- MACD
- ADTN -0.01
- ELYM 0.20
- Stochastic Oscillator
- ADTN 3.53
- ELYM 77.68
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About ELYM Eliem Therapeutics Inc
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).